Beclometasone/LABA showed no clear difference in pneumonia: participants with at least one (dichotomous Peto odds… compared with LABA (low certainty).
Beclometasone/LABA showed no clear difference in exacerbations: participants with at least one (dichotomous) compared with LABA (moderate certainty).
Beclometasone/LABA showed no clear difference in withdrawal (all‐cause) compared with LABA (moderate certainty).
Regular salmeterol showed no clear difference in all‐cause mortality ‐ adults and adolescents compared with placebo (moderate certainty).
Regular salmeterol showed no clear difference in all‐cause non‐fatal serious adverse events ‐ adults and adolescents compared with regular salbutamol (moderate certainty).
Regular salmeterol showed no clear difference in all‐cause non‐fatal serious adverse events ‐ children compared with regular salbutamol (moderate certainty).
Regular salmeterol showed no clear difference in asthma‐related mortality ‐ adults and adolescents compared with regular salbutamol (moderate certainty).
Regular salmeterol showed no clear difference in asthma‐related non‐fatal serious adverse events ‐ adults and… compared with regular salbutamol (low certainty).
Regular salmeterol showed no clear difference in asthma‐related non‐fatal serious adverse events ‐ children compared with regular salbutamol (low certainty).
Regular salmeterol leads to higher all‐cause non‐fatal serious adverse events ‐ adults and adolescents compared with placebo (high certainty).
Regular salmeterol showed no clear difference in all‐cause non‐fatal serious adverse events ‐ children compared with placebo (moderate certainty).
Regular salmeterol leads to higher asthma‐related mortality ‐ adults and adolescents compared with placebo (high certainty).
Regular salmeterol showed no clear difference in asthma‐related non‐fatal serious adverse events ‐ adults and… compared with placebo (low certainty).
Regular salmeterol showed no clear difference in asthma‐related non‐fatal serious adverse events ‐ children compared with placebo (moderate certainty).
Regular salmeterol showed no clear difference in all‐cause mortality ‐ adults and adolescents compared with regular salbutamol (moderate certainty).
Regular salmeterol showed no clear difference in all‐cause mortality ‐ children compared with regular salbutamol (low certainty).
Effects of different delivery devices on growth in children with… showed no clear difference in linear growth velocity (cm/year) compared with chlorofluorocarbon‐metered dose inhaler beclomethasone (low certainty).